Literature DB >> 11259083

Altered functional responses with preserved morphology of gonadotrophic cells in congenitally athymic mice.

R G Goya1, G M Cónsole, Y E Sosa, C L Gómez Dumm, M Dardenne.   

Abstract

Neonatal thymectomy or congenital absence of the thymus induces severe reproductive deficiencies in female mice, which are associated with reduced levels of circulating and pituitary gonadotropins. In contrast, the reproductive function is well preserved in nude males. It was therefore of interest to assess gonadotrophic cell morphology and function in congenitally athymic male mice. Circulating gonadotropins were measured under basal and stressful conditions, taking as a reference their haired counterparts. Adult normal (+/+), heterozygous nude (nu/+), and homozygous (nu/nu) CD-1 mice were subjected to 1-h immobilization stress. Serum levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were assessed by RIA at 0, 30, and 60 min poststress. Athymic animals showed significantly lower basal levels of serum LH and FSH than their heterozygous littermates. Immunohistochemical assessment of LH and FSH cell populations revealed a normal morphology and cell number in the athymic animals compared to their normal littermates. Immobilization stress induced a significant reduction in gonadotrophin levels, particularly LH, in normal mice but had only a weak effect in athymic animals. It is concluded that congenital athymia in the adult male mouse is associated with decreased basal levels of serum LH and FSH, in the presence of a normal gonadotroph number and morphology. The anomalous responses of athymic mice to stress do not appear to be due to primary hypopituitarism but, rather, to an altered modulation of pituitary hormone secretion. .

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259083     DOI: 10.1006/brbi.2000.0595

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  6 in total

1.  Thymulin-based gene therapy and pituitary function in animal models of aging.

Authors:  Paula C Reggiani; Brenda Poch; Gloria M Cónsole; Omar J Rimoldi; Jose I Schwerdt; Victoria Tüngler; Margarita M Garcia-Bravo; Mireille Dardenne; Rodolfo G Goya
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

2.  Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice.

Authors:  Rodolfo G Goya; Paula C Reggiani; Silvan M Vesenbeckh; Jean M Pléau; Yolanda E Sosa; Gloria M Cónsole; Rüdiger Schade; Peter Henklein; Mireille Dardenne
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-27       Impact factor: 4.310

3.  Partial prevention of hepatic lipid alterations in nude mice by neonatal thymulin gene therapy.

Authors:  Margarita M García de Bravo; Mónica P Polo; Paula C Reggiani; Omar J Rimoldi; Mireille Dardenne; Rodolfo G Goya
Journal:  Lipids       Date:  2006-08       Impact factor: 1.880

4.  The forkhead transcription factor, FOXP3, is required for normal pituitary gonadotropin expression in mice.

Authors:  Deborah O Jung; Jake S Jasurda; Noboru Egashira; Buffy S Ellsworth
Journal:  Biol Reprod       Date:  2012-05-10       Impact factor: 4.285

Review 5.  The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.

Authors:  Paula C Reggiani; Gustavo R Morel; Gloria M Cónsole; Claudio G Barbeito; Silvia S Rodriguez; Oscar A Brown; Maria Jose Bellini; Jean-Marie Pléau; Mireille Dardenne; Rodolfo G Goya
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

6.  Morphological restoration of gonadotrope population by thymulin gene therapy in nude mice.

Authors:  P Reggiani; E Martines; C Ferese; R Goya; G Cónsole
Journal:  Histol Histopathol       Date:  2009-06       Impact factor: 2.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.